25 of the Best Hematologist Oncologists Near Me

Nolan Priedigkeit, MD, PhD is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Instructor of Medicine at Harvard Medical School. Clinically, he specializes in breast cancer and his research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat metastatic disease. He received dual MD/PhD degrees from the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program where his thesis applied translational genomics to discover novel drug targets in advanced breast cancers. He completed an internal medicine residency at Brigham & Women’s Hospital, a medical oncology fellowship at Dana-Farber/Mass General Brigham, and currently leads multidisciplinary research projects at the Broad Institute of MIT & Harvard focused exclusively on breast cancer. He has been supported by awards from the National Cancer Institute, American Association for Cancer Research, Conquer Cancer Foundation of ASCO, Lubin Family Foundation, and the Susan G. Komen Foundation. He values patient-centered care with a focus on open and transparent communication, generous sharing of research data and ideas, as well as mentorship of trainees in both science and medicine. Dr. Priedigkeit is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Metastatic Brain Tumor. Dr. Priedigkeit is board certified in Internal Medicine.

Snegha Ananth is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 11 years. Dr. Ananth is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Mantle Cell Lymphoma (MCL).

As a doctor specializing in hematology and oncology, I take the time to explain diagnosis, prognosis, options and outcomes to my patients. I also provide education and practice shared decision making, which means I respect patient decisions. With the use of evidence-based medicine, I help patients fight cancer while focusing on their quality of life. Dr. Gummadi is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Gummadi is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine-Hematology, and American Board Of Internal Medicine-Medical Oncology. Dr. Gummadi is currently accepting new patients.

Gregory Roloff is a Hematologist and an Oncologist practicing medicine in Crown Point, Indiana. Dr. Roloff is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Adult T-Cell Leukemia, and Bone Marrow Transplant. Dr. Roloff is board certified in Hematology and Internal Medicine.

Vadim Zarubin is a Hematologist and an Oncologist practicing medicine in Waterbury, Connecticut. He has been practicing medicine for over 14 years. Dr. Zarubin is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Cavernous Sinus Thrombosis, and Pulmonary Embolism. Dr. Zarubin is board certified in American Board Of Internal Medicine, Medical Oncology and American Board Of Internal Medicine. Dr. Zarubin is currently accepting new patients.

Dr. Alumkal is the Wicha Family Professor of Oncology. He is the Leader of the Genitourinary Medical Oncology Section in the Hematology-Oncology Division and a Professor with tenure in the Department of Internal Medicine. He co-leads the Translational and Clinical Research Program in the Rogel Cancer Center. Dr. Alumkal’s main goal is to link laboratory and clinical scientists in order to develop more effective treatments for patients with advanced cancers, including men with prostate cancer whom he treats.Dr. Alumkal attended the University of Texas (UT) at Austin where he graduated summa cum laude with a B.A. in Biology. He attended medical school at Baylor College of Medicine. He completed internal medicine residency training at UT Southwestern Medical Center, where he also served as Chief Resident. He completed medical oncology training at Johns Hopkins University followed by a post-doctoral fellowship focused on cancer epigenetics at Johns Hopkins University. Subsequently, Dr. Alumkal joined Oregon Health & Science University from 2007-2019. There, Dr. Alumkal was the Co-Leader of the Prostate Cancer Section and the inaugural holder of the Wayne D. Kuni and Joan E. Kuni Foundation Endowed Chair for Prostate Cancer Research.Dr. Alumkal is a physician-scientist who was elected to the American Society for Clinical Investigation in 2019. The Alumkal Laboratory’s main emphasis is to understand how genes get turned off and on in advanced prostate cancers and how this process enables tumors to become resistant to standard treatments. The most important goals of Dr. Alumkal’s studies are to identify therapies that effectively target advanced prostate cancers and to conduct innovative clinical trials designed to validate the effectiveness of novel therapeutic agents.In his free time, Dr. Alumkal enjoys spending time with his two children and his wife Kathleen Kemmer—who is also a medical oncologist and faculty member in the Hematology-Oncology Division at the University of Michigan—reading, running, and watching/playing soccer. Dr. Alumkal is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer and Prostate Cancer. Dr. Alumkal is board certified in Medical Oncology.

Jonathan Trujillo is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Trujillo is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer and Familial Prostate Cancer. Dr. Trujillo is board certified in Internal Medicine and Medical Oncology.

Dr. Xiaolin Zhu is a genitourinary oncologist, a specialist in cancers of the urinary and reproductive systems. His focus is on caring for patients with prostate, bladder or kidney cancer. As a physician-scientist, Zhu studies biospecimens – for example, tumor and blood samples collected from patients – to understand how cancer evolves in response to treatments. He is a believer of precision oncology – tailoring treatments to the biological features of each individual patient's tumor. His goal is to develop innovative diagnostic tools and treatment options to improve patient outcomes. Zhu earned his medical degree at Shanghai Jiao Tong University School of Medicine in China. He earned a doctorate in genetics and genomics at Duke University. He completed a residency in internal medicine at University of Texas Southwestern Medical Center and a fellowship in hematology and oncology at UCSF. Zhu has received several awards, including the Young Investigator Award from Conquer Cancer, the ASCO (American Society of Clinical Oncology) Foundation and the Prostate Cancer Foundation, as well as the Physician Research Award from the Prostate Cancer Research Program at the Department of Defense. Outside of medicine, Zhu enjoys traveling, reading, and exploring new cuisines and music from around the world. Dr. Zhu is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, and Bladder Cancer. Dr. Zhu is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Zhu is currently accepting new patients.

Dr. William Moriconi is an oncologist who specializes in adult hematology and medical oncology for patients ages 30 and older. He treats solid tumors and hematologic malignancies, including colorectal, lung, non-Hodgkin's lymphoma, multiple myeloma, breast, and myeloproliferative disorders. He also provides outpatient infusion therapies. With more than 30 years of experience, Dr. Moriconi enjoys working with his patients and their families as they navigate the uncertainty and hardships that come with a cancer journey. He finds it incredibly rewarding when he encounters his patients, years after they've been cured, knowing he helped make a big difference in their lives. Dr. Moriconi is with the Division of Hematology, Oncology & Cellular Therapy in the Department of Internal Medicine at Saint Louis University School of Medicine. Interesting fact: Dr. Moriconi survived polio and numerous surgeries as child, which he credits with helping him become a better person and a more compassionate physician. Dr. Moriconi is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Lymphocytic Lymphoma (SLL), Myeloproliferative Neoplasms (MPN), and Lung Cancer. Dr. Moriconi is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine/Medical Oncology , Drug Enforcement Administration , Illinois Department Of Financial & Professional Regulation , Missouri Dept Of Health/Narcotics&Dangerous Drugs , and Missouri State Board Of Registration.

Naina Mahngar is a Hematologist and an Oncologist practicing medicine in Valparaiso, Indiana. Dr. Mahngar is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Mahngar is board certified in Hematology Internal Medicine.

Dr. Merz is from Spring Lake, MI. She earned a BA in Kinesiology and Spanish at Calvin College before obtaining her MD and Master's of Science in Clinical Research at the University of Michigan. She then completed internal medicine training at Brigham and Women's Hospital in Boston, MA before completing hematology/oncology fellowship at Dana-Farber Cancer Institute/Mass General Brigham.She joined the faculty at University of Michigan in 2025, specializing in women's health and classical hematology disorders like sickle cell disease, blood clots, ITP, or iron deficiency in pregnancy or with hormone therapy use.Dr. Merz's research work includes understanding the Duffy null phenotype-- a red blood cell variant common in people with African or Middle Eastern ancestry. She advocated to update the terminology around this variant to Duffy null-associated neutrophil counts (DANC), published the first Duffy null-specific absolute neutrophil count reference range, and was the principal investigator on a grant through the Doris Duke Foundation and the American Society of Hematology to accelerate the update of Duffy null reference ranges across the country. She now works to understand how to personalize diagnostics and treatment plans for people with the Duffy null variant-- especially in cancer care. She also does research in women's health and classical hematology including understanding how to prevent blood clots in pregnancy and optimizing iron stores throughout the reproductive lifespan.Outside of work, Dr. Merz is an active member in the Ann Arbor community and enjoys spending time with her husband and 2 greyhounds. Dr. Merz is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Agranulocytosis, Chronic Familial Neutropenia, Febrile Neutropenia, Thrombectomy, and Bone Marrow Transplant.

Poojitha Valasareddy is a Hematologist and an Oncologist practicing medicine in Highlands Ranch, Colorado. Dr. Valasareddy is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Melanoma, Pleuropulmonary Blastoma, Oral Squamous Cell Carcinoma, and Paget Disease of the Breast.

Pallavi Jasti is an Internal Medicine provider practicing medicine in Detroit, Michigan. Dr. Jasti is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Pancreatic Cancer.

Vinay Minocha is an Oncologist practicing medicine in Coral Springs, Florida. He has been practicing medicine for over 17 years. Dr. Minocha is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Minocha is currently accepting new patients.

Jose Paredes is a Hematologist and an Oncologist practicing medicine in Harvey, Illinois. Dr. Paredes is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Severe Congenital Neutropenia, and Childhood Iron Deficiency Anemia. Dr. Paredes is board certified in American Board Internal Medicine (Hematology) American Board Internal Medicine (Medical Oncology).

Gilberto Jimenez is a Hematologist and an Oncologist practicing medicine in Dallas, Texas. Dr. Jimenez is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Plasmacytoma, and Mantle Cell Lymphoma (MCL). Dr. Jimenez is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Hematology- American Board Of Internal Med/Hematology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, Hematology- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

As an hematologist and oncologist, I treat a variety of blood disorders and cancers. I have special interests in breast cancer, lung cancer, pancreatic cancer, and prostate cancer. I love to learn, and that’s very important in my patient care philosophy. I want to know about you and your background. I strive to understand the latest developments so that I can provide state-of-the-art care. I want to hear about ways you think we can provide better care for you and others. Along the way, I want to make sure you feel empowered to make medical decisions with me as your guide. Dr. Blazar is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Large-Cell Lung Carcinoma. Dr. Blazar is board certified in American Board Of Internal Medicine-Hematology and American Board Of Internal Medicine-Medical Oncology. Dr. Blazar is currently accepting new patients.

Julia Shih is an Oncologist practicing medicine in Camden, New Jersey. She has been practicing medicine for over 13 years. Dr. Shih is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Saddle Pulmonary Embolism, Prostate Cancer, and Familial Prostate Cancer. Dr. Shih is board certified in American Board Of Internal Medicine,Hematology , 2020, American Board Of Internal Medicine,Medical Oncology , 2020, and American Board Of Internal Medicine,Internal Medicine , 2017.

I am a board-certified hematologist-medical oncologist and the former department head for HealthPartners and HealthPartners Cancer Center at Regions Hospital. For more than 40 years, my career has been focused on medical education. I am an assistant professor in the Division of Hematology, Oncology and Transplantation at the University of Minnesota Medical School. I also have coordinated the Regions Hospital rotation for University of Minnesota hematology-oncology fellows and internal medicine residents. My practice included all aspects of hematology and oncology, with a particular interest in breast cancer and hematologic malignancies. I am now semi-retired and perform bone marrow diagnostic procedures in the HealthPartners Cancer Center at Regions Hospital as well as continued medical student, fellow and resident teaching. Dr. Jaffe is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Lynch Syndrome, and Non-Hodgkin Lymphoma. Dr. Jaffe is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine-Hematology, and American Board Of Internal Medicine-Medical Oncology.

Dr. David Oh is a medical oncologist who cares for patients who are receiving novel immunotherapies for cancers as part of clinical trials. These are treatments that harness the patient's own immune system to fight cancer. He specializes in prostate and bladder cancers. Oh's research focuses on understanding and improving cancer immunotherapies. He leads clinical trials to evaluate new immunotherapies for solid tumors, and he studies samples from patients who have received immunotherapies with the goal of better understanding their benefits and side effects. Oh earned his medical degree from Stanford University School of Medicine, where he also completed a doctorate in physiology. At UCSF, he completed a residency in internal medicine and a fellowship in hematology and oncology. Oh is a member of the American Society of Clinical Oncology, American Association for Cancer Research and Society for Immunotherapy of Cancer. He has received Young Investigator Awards from the Prostate Cancer Foundation, Bladder Cancer Advocacy Network and Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Oh is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Mesothelioma, and Neuroendocrine Tumor. Dr. Oh is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Oh is currently accepting new patients.

Mark Ratain is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Ratain is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Agranulocytosis, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Endoscopy. Dr. Ratain is board certified in Hematology Internal Medicine Medical Oncology and Practicing Since1986.

Dr. Shirin Attarian is a board-certified UCI Health medical oncologist who focuses on treating patients with head and neck cancer.She earned her medical degree at Shahid Beheshti Medical University in Tehran, Iran. She pursued a post-doctoral research fellowship at Massachusetts General Hospital, followed by a residency in internal medicine and fellowship in hematology/oncology at Albert Einstein College of Medicine in New York. Prior to joining UCI, Attarian served as an assistant professor at Northwell Health Cancer Institute in New York.Attarian's research interests include evaluating innovative treatment protocols for patients with head and neck cancer in clinical trials, improving the quality of life and symptoms in patients with head and neck cancer and clinical-epidemiological studies of head and neck cancer.She is deeply committed to providing leading-edge, compassionate, personalized, evidence-based and multidisciplinary care to her patients. Dr. Attarian is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Acute Intermittent Porphyria, Non-Small Cell Lung Cancer (NSCLC), Large-Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration. Dr. Attarian is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.

Schedule an appointment with Toros Ali Dincman, MD, PhD in Charleston, SC | Specializes in: Cancer - Gastrointestinal, Cancer - Prostate & Genitourinary, Hematology/Oncology | MUSC Health. Dr. Dincman is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer. Dr. Dincman is currently accepting new patients.

Dr. Hatem Hassanein is a board-certified and fellowship-trained hematologist and urologic medical oncologist at the Orlando Health Cancer Institute. He specializes in general hematology and urologic oncology. He diagnoses and treats patients with urologic cancers, including prostate, bladder, kidney and testicular, as well as patients with malignant and non-malignant hematologic disorders. His specialties also include: Chemotherapy Immunotherapy Hormone-based therapies Genetically targeted therapies Dr. Hassanein's Training Dr. Hassanein earned his medical degree and completed an internal medicine residency at the University of South Florida Morsani College of Medicine in Tampa. He performed a fellowship in hematology and oncology at the Orlando Health Cancer Institute. About Dr. Hassanein Dr. Hassanein is board certified in internal medicine by the American Board of Internal Medicine. He is a member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. He has been published in several medical journals and given presentations to national and international symposiums. Dr. Hassanein is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, and Embolectomy.

Alice Caffrey is an Oncologist practicing medicine in Worcester, Massachusetts. She has been practicing medicine for over 10 years. Dr. Caffrey is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Caffrey is board certified in Hematology , Internal Medicine , and Medical Oncology.